On this page you find listing prospectus since the IPO in 2019.
IPO prospectus for listing on NASDAQ Stockholm in March 2019
About us
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.
Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)
Download our fact sheet: Ascelia Pharma Factsheet Dec 2020
Latest news
- 2021-05-05Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021
- 2021-04-30Number of shares and votes in Ascelia Pharma AB
- 2021-04-15Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm
- 2021-04-13Bulletin from the extraordinary general meeting in Ascelia Pharma AB
- 2021-04-09Issue and repurchase of series C shares for share saving program
Events
- May 12 @ 08:00
Interim Report Q1 2021 (January-March 2021)
- May 25
ABGSC Life Science Summit
- May 25 @ 10:05 - 10:45
Imaging Event – Erik Penser Bank – 25 May 2021
- August 19 @ 08:00
Half-year report 2021 (April-June 2021)
- November 4 @ 08:00
Interim report 9M (January-September 2021)